Anebulo Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -110.7% | -110.7% | -100.5% |
| FY2024 | -215.1% | -215.1% | -201.4% |
| FY2025 | -72.8% | -72.8% | -69.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -110.7% | -110.7% | -100.5% |
| FY2024 | -215.1% | -215.1% | -201.4% |
| FY2025 | -72.8% | -72.8% | -69.9% |